Yuval Horn, Shimrit Roznek, Yael Bar Hillel and Taisia Kris represent VBL in the Agreement to Sell the Manufacturing Facility and Certain Related Assets for $7.1 Million.
February 23, 2023
Yuval Horn, Keren Kanir, Yonatan Levinstein and Dorin Cohn Arbel represented Immunorizon on the acquisition by Purple Biotech (NASDAQ/TASE: PPBT) in consideration for up to $100 million.
February 6, 2023
Shimrit Roznek Co-Chaired the IBA 5th Silicon Beach Conference on January 21-24, 2023
January 25, 2023
Yuval Horn, Assaf Unger and Ana Eiskov represented The INX Digital Company, Inc. in a joint venture with SICPA SA in the field of central bank digital currencies.
December 22, 2022
Uri Dotan and Shiran Glantz represent Pangea in its seed investment round
December 16, 2022
Yuval Horn & Shimrit Roznek represented Kamari Pharma in a Joint Venture Agreement raising 8 Million USD.
September 19, 2022
Yuval Horn, Yonatan Levinstein and Tal Gazanda represented Prisma Photonics in a strategic investment agreement with Israel Natural Gas Lines (INGL). Mazal tov to Eran Inbar and the team on this great vote of confidence!
August 2, 2022
Yuval Horn, Keren Kanir and Yonatan Levinstein represented Diagnostic Robotics in its Series B fundraising round lead by StageOne Ventures with participation by Mayo Clinic Ventures
July 26, 2022
Keren Kanir and Dorin Cohn Arbel advised Scopio Labs on its new and exciting distribution partnership with Beckman Coulter Diagnostics.
July 22, 2022
Uri Dotan and Shiran Glantz represented Nanosynex Ltd. In the control acquisition transaction with Qualigen Therapeutics, Inc. (NASDAQ:QLGN)
June 2, 2022
